PH18882A - Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones - Google Patents

Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones

Info

Publication number
PH18882A
PH18882A PH30115A PH30115A PH18882A PH 18882 A PH18882 A PH 18882A PH 30115 A PH30115 A PH 30115A PH 30115 A PH30115 A PH 30115A PH 18882 A PH18882 A PH 18882A
Authority
PH
Philippines
Prior art keywords
alkoxyphenyl
thiazolidinediones
aldose reductase
reductase inhibiting
inhibiting
Prior art date
Application number
PH30115A
Other languages
English (en)
Inventor
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH18882A publication Critical patent/PH18882A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Paints Or Removers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PH30115A 1983-01-17 1984-01-17 Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones PH18882A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45868483A 1983-01-17 1983-01-17

Publications (1)

Publication Number Publication Date
PH18882A true PH18882A (en) 1985-10-22

Family

ID=23821708

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30115A PH18882A (en) 1983-01-17 1984-01-17 Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones

Country Status (26)

Country Link
EP (1) EP0117035B1 (da)
JP (1) JPS59137474A (da)
KR (1) KR870001267B1 (da)
AT (1) ATE45574T1 (da)
AU (1) AU539921B2 (da)
CA (1) CA1233470A (da)
CS (1) CS241149B2 (da)
DD (1) DD216012A5 (da)
DE (1) DE3479419D1 (da)
DK (1) DK17984A (da)
EG (1) EG16563A (da)
ES (1) ES528887A0 (da)
FI (1) FI840155A7 (da)
GR (1) GR79763B (da)
GT (1) GT198400006A (da)
HU (1) HU191265B (da)
IE (1) IE56842B1 (da)
IL (1) IL70690A (da)
NO (1) NO162462C (da)
NZ (1) NZ206845A (da)
PH (1) PH18882A (da)
PL (1) PL142152B1 (da)
PT (1) PT77958B (da)
SU (1) SU1189341A3 (da)
YU (1) YU43336B (da)
ZA (1) ZA84305B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007056A1 (en) 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
GB8910639D0 (en) * 1989-05-09 1989-06-21 Beecham Group Plc Novel compounds
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
JP3053490B2 (ja) * 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−2,4−ジオン誘導体とその塩及び製造法
AU2018227588B2 (en) * 2017-03-03 2021-01-21 Gilead Sciences, Inc. Processes for preparing ACC inhibitors and solid forms thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2263296A1 (de) * 1972-12-23 1974-06-27 Bayer Ag 4-alkyl-thiazol-2-one, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPS56104876A (en) * 1980-01-24 1981-08-20 Takeda Chem Ind Ltd Thiazolidine derivative
JPS5728075A (en) * 1980-07-29 1982-02-15 Takeda Chem Ind Ltd Thiazolidine derivative
JPS5728073A (en) * 1980-07-29 1982-02-15 Takeda Chem Ind Ltd Inhibitor for aldose reducing enzyme
JPS57123175A (en) * 1981-01-26 1982-07-31 Takeda Chem Ind Ltd Preparation of thiazolidine derivative

Also Published As

Publication number Publication date
GR79763B (da) 1984-10-31
CS241149B2 (en) 1986-03-13
FI840155L (fi) 1984-07-18
EG16563A (en) 1989-06-30
HU191265B (en) 1987-01-28
JPH0329073B2 (da) 1991-04-23
NO840144L (no) 1984-07-18
PT77958A (en) 1984-02-01
AU539921B2 (en) 1984-10-25
CS38584A2 (en) 1985-07-16
EP0117035A2 (en) 1984-08-29
NO162462C (no) 1990-01-03
DK17984A (da) 1984-07-18
ES8506663A1 (es) 1985-08-01
SU1189341A3 (ru) 1985-10-30
IL70690A (en) 1989-01-31
NO162462B (no) 1989-09-25
IE840079L (en) 1984-07-17
PL245745A1 (en) 1984-10-22
YU6184A (en) 1986-06-30
FI840155A0 (fi) 1984-01-16
PL142152B1 (en) 1987-09-30
AU2328784A (en) 1984-07-19
PT77958B (en) 1986-06-18
IL70690A0 (en) 1984-04-30
DK17984D0 (da) 1984-01-16
FI840155A7 (fi) 1984-07-18
DD216012A5 (de) 1984-11-28
ES528887A0 (es) 1985-08-01
ATE45574T1 (de) 1989-09-15
NZ206845A (en) 1986-09-10
EP0117035A3 (en) 1987-01-14
GT198400006A (es) 1985-07-06
YU43336B (en) 1989-06-30
KR870001267B1 (ko) 1987-06-30
KR840007223A (ko) 1984-12-06
JPS59137474A (ja) 1984-08-07
EP0117035B1 (en) 1989-08-16
CA1233470A (en) 1988-03-01
ZA84305B (en) 1985-08-28
IE56842B1 (en) 1992-01-01
DE3479419D1 (en) 1989-09-21

Similar Documents

Publication Publication Date Title
IE791592L (en) Spiro-oxazole derivatives
AU697681B2 (en) Retroviral protease inhibiting compounds
AU7404791A (en) Treatment of cataract with 15-keto-prostaglandin compounds
EP0201742A3 (en) N-acylpyrrolidine derivatives, processes for preparing them, pharmaceutical composition and use
JPS56127379A (en) Hydantoin amine compound
IE791540L (en) Spiro-furanohydantoin derivatives
EG16563A (en) Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones
CA2030344A1 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
IE832854L (en) Spiro-3-hetero-azolones for treatment of diabetic¹complications.
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
DE3467166D1 (en) Spiro-succinimides for treatment of diabetes complications
EP0469782A3 (en) Treatment of cataract with prostacyclin compounds
DK0534655T3 (da) Thiazolidin-2,4-dioner til behandling af hypertension
DK495285A (da) Spiro-heteroazolon-forbindelser og farmaceutiske praeparater
RO87706A (ro) Procedeu pentru prepararea nizatidinei

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 11